Facilitation of infantile spasms by partial seizures

E J Carrazana1, C T Lombroso, M Mikati

  • 1Department of Neurology, Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Epilepsia
|January 1, 1993
PubMed

Insights

Infantile spasms in infants may be triggered by preceding partial seizures. This condition often shows poor response to standard treatments but may improve with surgery.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neuroscience

Background:

  • Infantile spasms are a severe epilepsy syndrome in infants.
  • The precise triggers and underlying mechanisms of infantile spasms remain under investigation.
  • Focal cerebral lesions are frequently observed in infants with infantile spasms.

Purpose of the Study:

  • To investigate the relationship between partial seizures and the onset of infantile spasms.
  • To characterize clinical and EEG features of infantile spasms associated with partial seizures.
  • To evaluate treatment responses and outcomes in this specific patient cohort.

Main Methods:

  • Retrospective analysis of 16 patients diagnosed with infantile spasms.
  • Detailed review of seizure semiology, EEG findings, neuroimaging, and treatment history.
  • Correlation of partial seizure occurrence with the onset of infantile spasms.
  • Assessment of response to adrenocorticotropic hormone (ACTH), antiepileptic drugs (AEDs), and surgical interventions.

Main Results:

  • 16 infants presented with infantile spasms triggered by preceding partial seizures.
  • Focal cerebral lesions were present in 12 infants; 3 had cryptogenic epilepsy.
  • Clusters of bilateral spasms consistently followed partial seizures with EEG localization.
  • Response to ACTH and traditional AEDs was generally poor.
  • Surgical cortical resections in 6 infants resulted in good outcomes.
  • Complete agenesis of the corpus callosum in 3 infants suggested spasms were not solely due to interhemispheric spread.

Conclusions:

  • Partial seizures may facilitate or induce infantile spasms, likely involving subcortical generation modulated by focal cortical discharges.
  • The findings support a model where focal cortical pathology plays a role in the pathogenesis of these spasms.
  • Surgical intervention can be an effective treatment option for selected infants with this specific presentation.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...